| |
|
June 23, 2016 |
|
| SMFM goes to Washington This past week, I had the pleasure of visiting Washington DC with members of the SMFM Health Policy and Advocacy Committee (HPAC). Dr. George Saade (chair of HPAC), Dr. Lisa Hollier (vice-chair of HPAC), Dr. Dan O'Keeffe (EVP of SMFM), Katie Schubert (SMFM Washington representative), Zara Day (Senior Policy Associate and Counsel at Cavarocchi Domenic Dennis), and I together visited a number of organizations and individuals to talk about SMFM and shared priorities. In addition to gaining insight into the activities of federal agencies and other groups, it was an opportunity to develop relationships, share ideas, and to emphasize our priorities for high-risk pregnancy care.During the trip, we met with members of several agencies and organizations: The conversations included a broad range of topics of interest to our members and our patients, including maternal mental health and peripartum depression, the Zika epidemic, disaster preparedness, the prenatal screening bill that is being considered by Congress, genetic education for patients and providers, and collaborative models of care. Some groups were quite familiar with SMFM, while others were not. But we were uniformly welcomed and left every meeting with many good ideas for further collaboration.
The Society's vision includes, among other things, leading the global advancement of women's and children's health through advocacy efforts, and the SMFM leadership visits Washington 2-3 times a year as part of our advocacy activity. As with our recent trip, the visits and priorities vary with what is happening in Congress and events such as the Zika outbreak. But it is a wonderful opportunity to meet stakeholders and collaborators in person, to ask how SMFM can help with their efforts, and to brainstorm ideas to effectively impact the health and well-being of pregnant women and children.
Katie Schubert, our SMFM advocacy representative, does a superb job arranging these meetings and representing us on the Hill throughout the year. Her column later in this newsletter has more detail about this latest trip as well as other HPAC activities. As always, feel free to contact me if you have thoughts or questions about these, or other, SMFM activities. Best, Mary |
|
SMFM Leaders Visit Washington, DC to Spread SMFM Message As Dr. Norton mentioned in her column, SMFM leaders visited Washington, DC on June 7 and 8 to meet with key federal agencies, Congressional offices and other advocacy organizations in the maternal and child health space. SMFM has been engaging in these types of activities for several years, reaching out to collaborators to spread the message about research and public health activities related to MFMs and high-risk pregnancy. The meetings will also inform SMFM's Health Policy & Advocacy Committee (HPAC) efforts related to federal policy agenda items over the next year. Currently the HPAC is tracking several pieces of legislation and working with federal agencies on the topics of medications in pregnancy, postpartum depression and quality maternity care, among others. Senate Committee Moves Forward on Labor-HHS-Education Funding BillOn June 9, 2016 the Senate Appropriations Committee approved its fiscal year 2017 spending bill for the U.S. Departments of Labor, Health and Human Services and Education. This bill received bipartisan support for the first time in seven years. Included in the report accompanying the bill was language related to research in preterm birth for which SMFM advocated. The bill would provide a $2 billion increase to the National Institutes of Health. Increases do come at the expense of other programs, with Committee Ranking Member Senator Barbara Mikulski (D-MD) noting that the bill cuts the CDC by $118 million. When the Budget Control Act was passed it put into place discretionary spending caps that Congress must adhere to or an across-the-board cut, known as sequestration, goes into effect. Therefore, any increase in funding in one place must be offset elsewhere. |
|
Select 2016 Publications & Guidelines: Read and/or search for more SMFM Publications & Guidelines online. |
|
AMFMM 8th Annual Business Meeting: September 22-23, San Diego, CA You and your office manager can enjoy this great educational and networking opportunity while learning more about:
|
|
ICD-10 indications for 76811 T |
|
|
|
Ways You Can Support The Pregnancy Foundation in 2016:
|
|
Pearls of Wisdom: "Should I pursue a niche?" By Dr. Richard L. Berkowitz People choosing to specialize in Maternal-Fetal Medicine have already opted to develop a niche in the general world of Obstetrics and Gynecology. The question to be addressed in this essay is whether further sub-specialization is worth pursuing. Let me begin by saying that, in my opinion, there is no right or wrong answer to that question. I know many MFM physicians who are extremely successful generalists in our field, as well as comparable numbers who have achieved recognition for their skills and/or knowledge in relatively small but well-defined niche areas. Therefore, I think the choice of what path to pursue depends entirely on an individual's career objectives. |
Fellow Tip of the Week Hepatocellular adenoma is an uncommon benign tumor of the liver that is rarely seen in pregnancy. Tumor size greater than 5cm is a good cutoff when thinking of increased maternal mortality, closer follow up and potential for intervention.- Contributor: Anonymous |
| |